1. Nicotine has been implicated as a causative factor in the intrauterine growth retardation associated with smoking in pregnancy. A study was set up to ascertain the effect of nicotine on fetal growth and whether this could be related to the actions of this drug on maternal adipose tissue metabolism.
Maternal smoking in pregnancy has been associated with low birth weights (Simpson, 1957; Save1 & Roth, 1962; Underwood et al. 1965; Landesman-Dwyer & Emanuel, 1979) , increased embryonic and fetal mortality (Meyer & Tonascia, 1977) , prematurity (Frazier et al. 1961) and increased incidence of congenital abnormalities (Naeye, 1978) . Nicotine has been implicated as the causative agent in many of these disturbances. In pregnant rats, nicotine administration causes delayed blastocyte implantation (Yoshinaga et al. 1979) , reduced embryo growth and retardation of parturition (Hammer & Mitchell, 1979 ). An effect of nicotine on birth weight, however, has not been clearly established. At levels of administration equivalent to those found in smokers, Becker el al. (1968) found no significant retardation of fetal growth, although at higher dose levels maternal appetite, weight gain and birth weight were all significantly reduced.
There are a number of mechanisms by which nicotine could impair fetal growth. It may act to decrease maternal appetite (Becker & King, 1966) , it may interfere with fetal blood supply by its vasoconstrictive effects on uterine blood flow (Bruce, 1979) or it may cause alterations in fetal and maternal metabolism.
Previous investigations of normal metabolism during rat, guinea-pig and human pregnancies have established pronounced alterations in maternal adipose tissue function. These changes are believed to be directed towards the maintenance of fetal growth, particularly in late gestation (Knopp et al. 1970; Coltart & Williams, 1976; Jones, 1976) . Since nicotine and smoking are known to produce disturbances in adipose tissue metabolism (Hershbaum et al. 1961; Bizzi et al. 1972) , it is possible that some of the harmful effects of nicotine in pregnancy may be attributed to its actions on this tissue.
In the present study we have investigated the effect of nicotine administration during pregnancy on weights at term and body composition of offspring. Rates of lipogenesis and lipolysis in maternal adipose tissue at term have also been studied. Nicotine; adipose tissue; f e t a l growth * For details of treatments, see p. 8.
R E S U L T S
Maternal weight gains Table 1 shows the weekly weight gains of animals in the control and nicotine groups and the total weight gains throughout pregnancy. In the 1st week of pregnancy, the nicotine group gained significantly less weight than the control animals; in some cases nicotine animals lost weight at this stage. Weight gains in the nicotine group were also reduced, compared with controls, during the 2nd week of pregnancy, although the difference was much less marked. In the 3rd and final week of pregnancy there was no significant difference in the weight gained by the two groups of animals. However, total weight gain remained significantly less in the nicotine group. Table 2 shows no effect of nicotine administration in pregnancy on fetal growth. This is evident from the similar values obtained for fetal body-weight, DNA and protein in the two groups. It was clear that neither cell number nor cell size were reduced in the nicotine animals. Protein: DNA values calculated for the nicotine and control groups were (mean with SE) 19.75 (1.06) and 18.80 (1.60) respectively. Examination of the number of pups in each litter suggested a possible effect of nicotine in reducing litter size, but this difference was not shown to be statistically significant ( P > 0.5). 
Fetal weights, D N A and protein contents, placental weights and litter sizes

Percentage body water and fat content
The mean values for percentage body water and fat content are shown in Table 3 . Values for body water were identical in the two groups. Body fat content was, however, significantly higher in the nicotine group. The higher fat content of offspring from nicotine-treated mothers did not appear to be related to an effect of litter size, since regression analysis showed body fat content and body-weight to be independent of the number of offspring in each litter.
Maternal adipose tissue lipogenesis and lipolysis Rates of lipogenesis and lipolysis in maternal adipose tissue are shown in Table 4 . There was no significant difference in lipogenic activity of tissue from the two groups of animals. Tissue from nicotine-treated animals did, however, show elevated rates of both basal and stimulated lipolysis. Under basal condition, glycerol release from adipose tissue was 65 % higher in the nicotine-treated animals. This difference was also seen when tissue was incubated under conditions of maximal stimulation, where nicotine-treated animals showed a 30% higher rate of in vitro lipolysis.
DISCUSSION
In the present study, impaired maternal weight gains of nicotine-treated pregnant rats were not accompanied by corresponding reductions in body-weights or cellularity of offspring.
These findings lend support to the view that nicotine is not a major factor in the fetal growth retardation associated with smoking in pregnancy. Haworth & Ford (1972) showed that exposure of pregnant rats to tobacco smoke resulted in reduced body-weight and DNA and protein contents of offspring. Since previous investigations had shown no effect of nicotine or carbon monoxide (Younoszai et al. 1969), Haworth & Ford (1972) attributed these findings to an 'unidentified component of tobacco smoke'. It is clear that adverse effects of nicotine on body-weights of offspring reported by previous authors may be attributable to the very high doses used (Becker et al. 1968; Hudson & Timiras, 1972) . Marked behavioural changes and impaired maternal appetites were observed in these studies. The doses employed in the present study were comparable with those of a 60 kg woman smoking twenty cigarettes daily. No adverse behavioural changes were observed and food intakes were similar in both groups of animals.
The effects of nicotine on maternal weight gain were seen to be most marked during the 1st week of pregnancy, when fetal growth is low but maternal weight gain is accelerated. Much of the weight gain observed during this period is attributed to increased lipid deposition in maternal adipose tissue (Fain & Scow, 1966; Smith, 1973) . In rat and human pregnancies, total body fat and fat cell size are increased during this early anabolic phase (Beaton et al. 1954; Pipe et al. 1979) . Since nicotine is known to cause depletion of body fat in the rat (Thiennes & Behrend, 1933) , it seems likely that the retarded weight gains of the nicotine-treated mothers in early pregnancy represents a failure of this normal fat deposition.
It is well established in rat, guinea-pig and human pregnancies that late gestation represents a period of increased catabolism in the maternal system. Adipose tissue lipolysis and sensitivity to lipolytic agents are increased (Knopp et al. 1970; Elliott, 1975; Coltart & Williams, 1976; Jones, 1976) and fasting produces greater increases in plasma fatty acid and ketone levels and greater falls in blood glucose (Herrera et al. 1969; Felig & Lynch, 1970) . These changes are thought to be directed towards ensuring the maintenance of adequate fetal nutrition at the time of maximal growth rates (Knopp et al. 1973) .
From the present investigation, it seems that nicotine enhances the catabolic state of adipose tissue at term, since both basal and stimulated lipolysis were higher in the nicotine-treated animals. The lipolytic actions of nicotine are believed to be due to increased catecholamine release from the adrenal medulla (Hershbaum et al. (1963) . Since adipose tissue from pregnant animals shows greater sensitivity to the lipolytic actions of catecholamines (Knopp et al. 1970) , the observed rates of lipolysis in nicotine-treated animals is most likely due to raised circulating levels of catecholamines. Rates of lipogenesis were shown to be similar in the two groups of animals; as lipolysis was shown to be raised in the nicotine-treated group, depletion of adipose tissue mass most likely occurred in these animals.
In the fetus, the effects of nicotine appear to be contrary to those observed in the mothers, since percentage body fat was higher in offspring of nicotine-treated mothers. It seems reasonable to propose that the increased adiposity recorded in the offspring from nicotine-treated mothers is directly due to increased release and transport of fatty acids from maternal adipose tissue to fetal circulation. This is despite evidence of poor permeability to fatty acids reported in the rat (Koren & Shafrir, 1964) . In other species, including man and guinea-pig, the placenta appears to be much more permeable to fatty acids (Szabo et al. 1969; Szabo & Grimaldi, 1970) . In vitro studies of human placentas have demonstrated that the maternal-fetal concentration gradient is the major factor determining the rate of transport of fatty acids (Booth et al. 1981) . It seems probable that any factor causing elevation of maternal plasma fatty acids will lead to increased placental transport and greater fetal adiposity. This has been demonstrated in the rabbit where maternal starvation was shown to cause increased transport and deposition of fatty acids in fetal tissues (Elphick et al. 1978) . It is tempting to speculate that in species showing greater placental permeability to fatty acids than the rat, the lipolytic actions of nicotine are likely to produce more pronounced effects on fetal adiposity than those observed here.
It may be concluded from the present investigation that the intra-uterine growth retardation associated with smoking in pregnancy may not be due to the actions of nicotine. Rather, this drug, by its lipolytic actions on the maternal system, leads to greater fat deposition in the fetus. It cannot, however, be concluded that the observed actions of nicotine are harmless to the mother or the developing fetus. By its actions in increasing lipolysis and raising maternal fatty acid levels, it may exacerbate the ketosis of short-term fasting observed in pregnant animals and man. This may be deterimental to offspring since ketone acids are taken up by the fetus and may replace glucose as an energy-yielding substance, particularly in the brain (Dahlquist et al. 1972) . Frequent ketonuria in pregnancy is regarded as a risk factor, since there is evidence of impaired intellectual and psychological development in offspring of ketotic diabetic and nondiabetic mothers . The effects of nicotine on fetal adiposity may also be harmful since, if birth weight alone is used as an assessment of intra-uterine growth, greater adiposity may mask growth retardation produced by other components of cigarette smoke. By reducing early-pregnancy fat deposition in the mother, nicotine may reduce the capacity of the nursing mother to meet the energy demands of lactation, particularly when dietary intake is restricted. It would appear that the actions of nicotine in pregnancy may have important nutritional consequences, both to the offspring and mother. These effects warrant further investigation.
